IQ EQ FUND MANAGEMENT IRELAND Ltd Increases Stock Holdings in Xylem Inc. (NYSE:XYL)

IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its position in shares of Xylem Inc. (NYSE:XYL) by 7.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,137 shares of the industrial products company’s stock after purchasing an additional 2,546 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Xylem were worth $5,015,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Duality Advisers LP purchased a new stake in shares of Xylem during the 1st quarter valued at approximately $6,746,000. Russell Investments Group Ltd. raised its position in Xylem by 12.9% in the first quarter. Russell Investments Group Ltd. now owns 338,315 shares of the industrial products company’s stock valued at $43,737,000 after purchasing an additional 38,603 shares during the period. California State Teachers Retirement System lifted its stake in shares of Xylem by 1.4% in the 1st quarter. California State Teachers Retirement System now owns 393,856 shares of the industrial products company’s stock valued at $50,902,000 after purchasing an additional 5,477 shares during the last quarter. Central Pacific Bank Trust Division purchased a new position in shares of Xylem during the 1st quarter worth $1,487,000. Finally, Daiwa Securities Group Inc. grew its holdings in shares of Xylem by 25.8% during the 1st quarter. Daiwa Securities Group Inc. now owns 69,701 shares of the industrial products company’s stock worth $9,008,000 after purchasing an additional 14,276 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Price Performance

Shares of NYSE XYL opened at $137.46 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.85 and a quick ratio of 1.33. The company has a market cap of $33.33 billion, a price-to-earnings ratio of 48.92, a price-to-earnings-growth ratio of 2.42 and a beta of 1.04. The stock’s 50-day moving average is $133.42 and its two-hundred day moving average is $135.04. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The firm had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.14 billion. During the same period in the prior year, the firm earned $0.98 earnings per share. The business’s quarterly revenue was up 26.0% compared to the same quarter last year. Analysts forecast that Xylem Inc. will post 4.26 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th were issued a $0.36 dividend. The ex-dividend date of this dividend was Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. Xylem’s payout ratio is 51.25%.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Stifel Nicolaus upped their target price on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. TD Cowen reissued a “hold” rating and issued a $138.00 price target on shares of Xylem in a research note on Tuesday, September 3rd. Robert W. Baird increased their price objective on shares of Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 31st. Royal Bank of Canada boosted their target price on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Finally, UBS Group initiated coverage on Xylem in a research note on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective for the company. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $149.67.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.